Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diabetes stakeholders oppose competitive bidding

This article was originally published in The Gray Sheet

Executive Summary

The National Association of Chain Drug Stores maintains that inclusion of diabetes products in the impending DMEPOS competitive bidding program may prevent patient access to the most appropriate equipment and supplies. NACDS cites a report by Health Policy R&D, indicating that failing to control glucose levels is significantly more costly than the costs of glucose meters and related supplies. The request to exclude diabetes products reiterates pleas made by industry stakeholders during a Program Advisory & Oversight Committee meeting in Sept. 2005 (1"The Gray Sheet" Oct. 3, 2005, p. 15). Under Sec. 302 of the Medicare Modernization Act, durable medical equipment, prosthetics, orthotics and supplies will be subject to competitive bidding in 2007 (2"The Gray Sheet" Jan. 23, 2006, p. 16)...
Advertisement

Related Content

DME Competitive Bidding Program Not Likely To Begin Until After Jan. 2007
Diabetes Products Should Be Exempt From Competitive Bidding – Panel
Diabetes Products Should Be Exempt From Competitive Bidding – Panel
Advertisement
UsernamePublicRestriction

Register

MT023308

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel